We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-25.00 | -1.09% | 2,265.00 | 2,250.00 | 2,280.00 | 2,275.00 | 2,250.00 | 2,275.00 | 28,684 | 09:38:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 174.02M | 9.23M | 0.2626 | 86.25 | 796.32M |
TIDMCRW
RNS Number : 0253V
Craneware plc
31 October 2017
Craneware plc
("Craneware", "the Group" or the "Company")
Significant Contract Win
31 October 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the renewal and significant expansion of an existing contract with a growing hospital operator in the US.
This $6m win sees the extension of a relationship that has been in place since 2007, with the renewal of the customer's existing Value Cycle solutions and the roll out of these same solutions to further facilities that have been recently acquired by this hospital network. The contract is expected to deliver $3.5m of incremental revenue over this new five year term as the hospital network rolls out these solutions at its additional facilities.
In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.
Keith Neilson, CEO of Craneware plc, commented, "The expansion of this relationship demonstrates the strategic importance of Craneware's Value Cycle solutions to our customers, as they extend their own hospital networks throughout the US. The strength of our solutions and the value they deliver to all customers, including large and complex health systems, allows us to deepen our relationship with our customers as they address the challenges resulting from the continued evolution to the new value based re-imbursement environment.
"Having enjoyed our positive working relationship for a decade, we now look forward to continuing to deliver sustainable value throughout this new term."
For further information, please contact:
Craneware Peel Hunt Alma plc +44 (0)131 +44 (0)20 +44 (0)208 550 3100 7418 8900 004 4218 Keith Neilson, Dan Webster Caroline Forde CEO Craig Preston, Adrian Trimmings Hilary Buchanan CFO George Sellar Robyn McConnachie Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTGMMFGLGLGNZM
(END) Dow Jones Newswires
October 31, 2017 03:00 ET (07:00 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions